当前位置：
X-MOL 学术
›
Lancet Diabetes Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Methodological considerations in D-health cancer mortality results – Authors' reply
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2022-04-21 , DOI: 10.1016/s2213-8587(22)00107-3 Rachel E Neale 1 , Briony Duarte Romero 2 , Donald S A McLeod 3 , Dallas R English 4 , Gunter Hartel 2 , Jolieke C van der Pols 5 , Alison J Venn 6 , Penelope M Webb 7 , David C Whiteman 7 , Mary Waterhouse 2
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2022-04-21 , DOI: 10.1016/s2213-8587(22)00107-3 Rachel E Neale 1 , Briony Duarte Romero 2 , Donald S A McLeod 3 , Dallas R English 4 , Gunter Hartel 2 , Jolieke C van der Pols 5 , Alison J Venn 6 , Penelope M Webb 7 , David C Whiteman 7 , Mary Waterhouse 2
Affiliation
Abstract not available
中文翻译：
D-health 癌症死亡率结果中的方法学考虑——作者的答复
摘要不可用
更新日期：2022-04-22
中文翻译：
D-health 癌症死亡率结果中的方法学考虑——作者的答复
摘要不可用
京公网安备 11010802027423号